These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8728832)

  • 1. Cholesterol-lowering effects of policosanol in rabbits.
    Arruzazabala ML; Carbajal D; Mas R; Molina V; Valdes S; Laguna A
    Biol Res; 1994; 27(3-4):205-8. PubMed ID: 8728832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits.
    Mendoza S; Gamez R; Mas R; Goicochea E
    Int J Tissue React; 2003; 25(3):81-9. PubMed ID: 14756189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sugar cane policosanol on lipid profile in primary hypercholesterolemia.
    Francini-Pesenti F; Beltramolli D; Dall'acqua S; Brocadello F
    Phytother Res; 2008 Mar; 22(3):318-22. PubMed ID: 18167048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.
    Castaño G; Mas R; Fernández L; Illnait J; Gámez R; Alvarez E
    Int J Clin Pharmacol Res; 2001; 21(1):43-57. PubMed ID: 11708574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Policosanol inhibits cholesterol biosynthesis and enhances low density lipoprotein processing in cultured human fibroblasts.
    Menendez R; Fernandez SI; Del Rio A; Gonzalez RM; Fraga V; Amor AM; Mas RM
    Biol Res; 1994; 27(3-4):199-203. PubMed ID: 8728831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of policosanol in hypercholesterolemic postmenopausal women.
    Mirkin A; Mas R; Martinto M; Boccanera R; Robertis A; Poudes R; Fuster A; Lastreto E; Yañez M; Irico G; McCook B; Farré A
    Int J Clin Pharmacol Res; 2001; 21(1):31-41. PubMed ID: 11708573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of policosanol on arterial blood pressure in rats. Study of the pharmacological interaction with nifedipine and propranolol.
    Molina Cuevas V; Arruzazabala ML; Carbajal Quintana D; Más Ferreiro R; Valdés García S
    Arch Med Res; 1998; 29(1):21-4. PubMed ID: 9556918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.
    Castaño G; Más R; Arruzazabala ML; Noa M; Illnait J; Fernández JC; Molina V; Menéndez A
    Int J Clin Pharmacol Res; 1999; 19(4):105-16. PubMed ID: 10939028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial.
    Cubeddu LX; Cubeddu RJ; Heimowitz T; Restrepo B; Lamas GA; Weinberg GB
    Am Heart J; 2006 Nov; 152(5):982.e1-5. PubMed ID: 17070175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the effects of D-003 and policosanol (5 and 10 mg/day) in patients with type II hypercholesterolemia: a randomized, double-blinded study.
    Castaño G; Más R; Fernández L; Illnait J; Mendoza S; Gámez R; Fernández J; Mesa M
    Drugs Exp Clin Res; 2005; 31 Suppl():31-44. PubMed ID: 16444910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sugar cane policosanol failed to lower plasma cholesterol in primitive, diet-resistant hypercholesterolaemia: a double blind, controlled study.
    Francini-Pesenti F; Brocadello F; Beltramolli D; Nardi M; Caregaro L
    Complement Ther Med; 2008 Apr; 16(2):61-5. PubMed ID: 18514906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
    Castaño G; Menéndez R; Más R; Amor A; Fernández JL; González RL; Lezcay M; Alvarez E
    Int J Clin Pharmacol Res; 2002; 22(3-4):89-99. PubMed ID: 12837046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effect of sugar cane policosanol on plasma cholesterol in Golden Syrian hamsters.
    Kassis AN; Marinangeli CP; Jain D; Ebine N; Jones PJ
    Atherosclerosis; 2007 Sep; 194(1):153-8. PubMed ID: 17123537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant use of policosanol and beta-blockers in older patients.
    Castaño G; Mas R; Gámez R; Fernández J; Illnait J; Fernández L; Mendoza S; Mesa M; Gutiérrez JA; López E
    Int J Clin Pharmacol Res; 2004; 24(2-3):65-77. PubMed ID: 15689053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of lycopene and fluvastatin effects on atherosclerosis induced by a high-fat diet in rabbits.
    Hu MY; Li YL; Jiang CH; Liu ZQ; Qu SL; Huang YM
    Nutrition; 2008 Oct; 24(10):1030-8. PubMed ID: 18585898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus.
    Crespo N; Illnait J; Más R; Fernández L; Fernández J; Castaño G
    Int J Clin Pharmacol Res; 1999; 19(4):117-27. PubMed ID: 10939029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia.
    Castaño G; Fernández L; Mas R; Illnait J; Gámez R; Mendoza S; Mesa M; Fernández J
    Drugs R D; 2005; 6(4):207-19. PubMed ID: 16050054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of concurrent therapy with policosanol and omega-3 fatty acids on lipid profile and platelet aggregation in rabbits.
    Gámez R; Máz R; Arruzazabala ML; Mendoza S; Castaño G
    Drugs R D; 2005; 6(1):11-9. PubMed ID: 15806713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy, safety and tolerability of original policosanol versus other mixtures of higher aliphatic primary alcohols in patients with type II hypercholesterolemia.
    Castaño G; Fernández L; Mas R; Illnait J; Fernández J; Mesa M; Alvarez E; Lezcay M
    Int J Clin Pharmacol Res; 2002; 22(2):55-66. PubMed ID: 12503776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative effects of policosanol and two HMG-CoA reductase inhibitors on type II hypercholesterolemia].
    Prat H; Román O; Pino E
    Rev Med Chil; 1999 Mar; 127(3):286-94. PubMed ID: 10436712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.